HC Wainwright&Co.:维持Assertio Holdings(ASRT.US)评级,由买入调整至买入评级,目标价由4.00美元调整至3.50美元。Assertio(ASRT.US)公司简介:Assertio Holdings Inc是一家制药公司。它致力于提供解决方案,以推进神经病学、孤儿药和特殊医学领域的患者护理。该公司销售三种FDA批准的用于各种神经系统疾病的产品,包括...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.